Read the full stored bill text
A4579
ASSEMBLY, No. 4579
STATE OF NEW JERSEY
222nd LEGISLATURE
�
INTRODUCED MARCH 10, 2026
Sponsored by:
Assemblywoman� VERLINA REYNOLDS-JACKSON
District 15 (Hunterdon and Mercer)
Assemblywoman� AURA K. DUNN
District 25 (Morris and Passaic)
Assemblywoman� LINDA S. CARTER
District 22 (Somerset and Union)
Co-Sponsored by:
Assemblymen Stanley, Sampson, Scharfenberger, Assemblywoman
Peterpaul, Assemblymen Miller, Auth, Assemblywoman Sweeney, Assemblymen
Karabinchak, DePhillips, Kennedy, Assemblywoman Rowan, Assemblymen Rumpf,
Myhre, Azzariti Jr., Assemblywomen Flynn, Donlon, Assemblymen Danielsen and
Inganamort
SYNOPSIS
���� Increases amount of cigarette and other tobacco
products tax revenues provided to New Jersey Commission on Cancer Research to
$10 million; establishes dedicated, non-lapsing Cancer Research Fund.
CURRENT VERSION OF TEXT
���� As introduced.
��
An Act
concerning the New Jersey State Commission on
Cancer Research, amending P.L.1982, c.40, supplementing P.L.1983, c.6, and
repealing section 8 of P.L.1983, c.6.
����
Be It
Enacted
by the Senate and General Assembly of
the State of New Jersey:
����� 1.�� Section
5 of P.L.1982, c.40 (C.54:40A-37.1) is amended as follows:
����� 5.�� The
sum of
[
$1,000,000.00
]
$10,000,000
of the tax collected pursuant to
section 301 of P.L.1948, c.65 (C.54:40A-8), shall be
annually
deposited
by the State Treasurer in
[
a special
account to be known as
]
the Cancer
Research Fund,
[
except that
for Fiscal Year 1983 only $500,000.00 shall be deposited in that account
]
a nonlapsing, revolving fund established
pursuant to section 3 of P.L.� ��,
c.��� (C.������� ) (pending before
the Legislature as this bill)
.� Moneys in the Cancer Research Fund shall be
[
annually appropriated toward
the funding of
]
utilized
by
the New Jersey State Commission on Cancer Research
,
established
pursuant to P.L.1983, c.6 (C.52:9U-1 et seq.),
[
or to
]
for cancer
research
projects authorized and approved by the commission
with at
least $5,000,000 in moneys from the fund being used to fund general cancer
research and at least $5,000,000 in moneys from the fund being used to fund
pediatric cancer research
.
(cf:
P.L.1990, c.39, s.18)
����� 2.�� Section 8 of P.L.1983, c.6 (C.52:9U-8) is repealed.
����� 3.�� (New
Section) a. There is established in the Department of the Treasury a nonlapsing,
revolving fund to be known as the Cancer Research Fund.� This fund shall be the
repository for monies provided pursuant to section 5 of P.L.1982, c.40
(C.54:40A-37.1) and any other funds approved by the Department of Health or the
commission.� Moneys deposited in the fund, and any interest earned thereon,
shall be used exclusively for providing grants, as well as contracts, for
general cancer research projects and pediatric cancer research projects,
authorized and approved by the commission.�
����� b.�� The
State Treasurer shall be the custodian of the fund and all disbursements from
the fund shall be made by the State Treasurer upon vouchers signed by the
chairperson of the commission or the chairperson�s designee.� The monies in the
fund shall be invested and reinvested by the Director of the Division of
Investment in the Department of the Treasury in the same manner as other trust
funds in the custody of the State Treasurer, in the manner provided by law.�
Interest received on the monies in the fund shall be credited to the fund.
���� 4.��� This act shall take
effect immediately.
STATEMENT
���� T
his bill increases the amount of cigarette and other
tobacco products tax revenues provided to the New Jersey Commission on Cancer
Research (NJCCR) to $10 million.� The bill also establishes a dedicated,
non-lapsing Cancer Research Fund within the Department of the Treasury.� In
doing so, the bill prioritizes funding: 1) to expand the NJCCR�s capacity to
fund research regarding the causes, prevention, treatment, and palliation of
all cancers and to serve as a resource of information to providers and consumers
of cancer care and treatment services; and 2) for cancer research grants that
reduce and eliminate disparities among the various racial and ethnic
populations within the State�s minority and vulnerable communities by
increasing access to clinical trials and high-quality cancer care and
treatment.�
����� Pursuant to current statute, the NJCCR annually
receives $1 million in cigarette and other tobacco products tax revenues.� This
money is deposited into an existing lapsing Cancer Research Fund and then
appropriated to the commission.� In recent years, pursuant to the annual
appropriations act, this money has been transferred from the Cancer Research
Fund to the General Fund.� The appropriations act then provides the NJCCR
funding via a budget line.� Despite the statutory requirement, in FY 2024, the
NJCCR was appropriated $4 million in funding.�
����� Under the bill, the existing lapsing Cancer Research
Fund is replaced by a non-lapsing, revolving fund.� This fund is to be the
repository of the $10 million in cigarette and other tobacco products tax
revenues deposited into the account under the bill and any other funds approved
by the Department of Health or the NJCCR.� Moneys deposited in the fund, and
any interest earned thereon, are to be used exclusively for providing grants
for cancer research projects authorized and approved by the commission, with at
least $5 million to be used to fund general cancer research and at least $5
million to be used to fund pediatric cancer research.�
����� The State Treasurer will be the custodian of the fund
and all disbursements from the fund are to be made by the State Treasurer upon
vouchers signed by the chairperson of the NJCCR or the chairperson�s designee.�
The monies in the fund are to be invested and reinvested by the Director of the
Division of Investment in the Department of the Treasury in the same manner as
other trust funds in the custody of the State Treasurer, in the manner provided
by law.� Interest received on the monies in the fund are to be credited to the
fund.